IIL begins Covaxin drug material supplies

In a move that will boost the production capacity of indigenously developed Covid-19 vaccine Covaxin, Indian Immunologicals Ltd (IIL) on Friday handed over the first batch of Covaxin drug substance produced at its Karakapatla facility in Genome Valley to Bharat Biotech.

Original source: https://health.economictimes.indiatimes.com/news/pharma/85318746?utm_source=RSS&utm_medium=ETRSS

Related Posts